<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Acta Ophthalmol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Acta Ophthalmol</journal-id>
      <journal-id journal-id-type="doi">10.1111/(ISSN)1755-3768</journal-id>
      <journal-id journal-id-type="publisher-id">AOS</journal-id>
      <journal-title-group>
        <journal-title>Acta Ophthalmologica</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1755-375X</issn>
      <issn pub-type="epub">1755-3768</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26612193</article-id>
      <article-id pub-id-type="pmc">5063120</article-id>
      <article-id pub-id-type="doi">10.1111/aos.12909</article-id>
      <article-id pub-id-type="publisher-id">AOS12909</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Letter to the Editor</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Sneddon's syndrome with optic disc macroaneurysm and macular edema successfully treated with subtenon steroid injection</article-title>
        <alt-title alt-title-type="left-running-head"><sc>acta ophthalmologica</sc> 2015</alt-title>
      </title-group>
      <contrib-group>
        <contrib id="aos12909-cr-0001" contrib-type="author">
          <name>
            <surname>Nagai</surname>
            <given-names>Norihiro</given-names>
          </name>
          <xref ref-type="aff" rid="aos12909-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aos12909-aff-0002">
<sup>2</sup>
</xref>
          <xref ref-type="author-notes" rid="aos12909-note-0001">
<sup>&#x2020;</sup>
</xref>
        </contrib>
        <contrib id="aos12909-cr-0002" contrib-type="author">
          <name>
            <surname>Ohta</surname>
            <given-names>Yuka</given-names>
          </name>
          <xref ref-type="aff" rid="aos12909-aff-0002">
<sup>2</sup>
</xref>
          <xref ref-type="author-notes" rid="aos12909-note-0001">
<sup>&#x2020;</sup>
</xref>
        </contrib>
        <contrib id="aos12909-cr-0003" contrib-type="author">
          <name>
            <surname>Izumi&#x2010;Nagai</surname>
            <given-names>Kanako</given-names>
          </name>
          <xref ref-type="aff" rid="aos12909-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aos12909-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="aos12909-cr-0004" contrib-type="author">
          <name>
            <surname>Shinoda</surname>
            <given-names>Hajime</given-names>
          </name>
          <xref ref-type="aff" rid="aos12909-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="aos12909-cr-0005" contrib-type="author">
          <name>
            <surname>Tsubota</surname>
            <given-names>Kazuo</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8874-7111</contrib-id>
          <xref ref-type="aff" rid="aos12909-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="aos12909-cr-0006" contrib-type="author" corresp="yes">
          <name>
            <surname>Ozawa</surname>
            <given-names>Yoko</given-names>
          </name>
          <address>
            <email>ozawa@a5.keio.jp</email>
          </address>
          <xref ref-type="aff" rid="aos12909-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aos12909-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aos12909-aff-0001">
        <label>
          <sup>1</sup>
        </label>
        <named-content content-type="organisation-division">Laboratory of Retinal Cell Biology</named-content>
        <institution>Keio University School of Medicine</institution>
        <named-content content-type="city">Shinjuku&#x2010;ku</named-content>
        <named-content content-type="city">Tokyo</named-content>
        <country country="JP">Japan</country>
      </aff>
      <aff id="aos12909-aff-0002">
        <label>
          <sup>2</sup>
        </label>
        <named-content content-type="organisation-division">Department of Ophthalmology</named-content>
        <institution>Keio University School of Medicine</institution>
        <named-content content-type="city">Shinjuku&#x2010;ku</named-content>
        <named-content content-type="city">Tokyo</named-content>
        <country country="JP">Japan</country>
      </aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label><italic>Correspondence</italic>:
<break/>
Yoko Ozawa, MD, PhD<break/>
Laboratory of Retinal Cell Biology<break/>
Department of Ophthalmology<break/>
Keio University School of Medicine<break/>
35 Shinanomachi, Shinjuku&#x2010;ku<break/>
Tokyo 160&#x2010;8582, Japan<break/>
Tel: +81 3 5363 3869<break/>
Fax: +81 3 5363 3869<break/>
Email: <email>ozawa@a5.keio.jp</email><break/></corresp>
        <fn fn-type="equal" id="aos12909-note-0001">
          <label>&#x2020;</label>
          <p>Equal contribution as first authors to the study.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <volume>94</volume>
      <issue>6</issue>
      <issue-id pub-id-type="doi">10.1111/aos.2016.94.issue-6</issue-id>
      <fpage>e517</fpage>
      <lpage>e519</lpage>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2016 Acta Ophthalmologica Scandinavica Foundation <copyright-statement>-->
        <copyright-statement content-type="article-copyright">&#xA9; <italic>2015 The Authors. Acta Ophthalmologica published by John Wiley &amp; Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation</italic>.</copyright-statement>
        <license license-type="creativeCommonsBy-nc-nd">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution&#x2010;NonCommercial&#x2010;NoDerivs</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#x2010;commercial and no modifications or adaptations are made.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:AOS-94-e517.pdf"/>
      <counts>
        <fig-count count="1"/>
        <table-count count="0"/>
        <page-count count="2"/>
        <word-count count="974"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>aos12909</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>September 2016</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.4 mode:remove_FC converted:13.10.2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>
<named-content content-type="salutation">Editor,</named-content>
</p>
    <sec id="aos12909-sec-0001">
      <p>Here, we report a patient with Sneddon's syndrome who developed optic disc macroaneurysm and resulting macular oedema, which was successfully treated with a posterior subtenon injection of triamcinolone acetonide (STTA).</p>
      <p>In March 2014, a 48&#x2010;year&#x2010;old man with impaired central vision and image distortion in his right eye was referred to the Medical Retina Division Clinic of Department of Ophthalmology, Keio University Hospital (Tokyo, Japan). His right fundus showed optic disc macroaneurysm (Fig.&#xA0;<xref rid="aos12909-fig-0001" ref-type="fig">1</xref>A, arrow) and macular oedema with hard exudates. His visual acuity (VA) was 1.0 in decimal VA (0 in logMAR) at the first visit. Fundus fluorescein angiography (FFA) showed delayed perfusion in an inferotemporal branch retinal artery (arm to the branch perfusion time, 31&#xA0;seconds; Fig.&#xA0;<xref rid="aos12909-fig-0001" ref-type="fig">1</xref>B, arrowheads) and optic disc macroaneurysm at the beginning of the branch artery (Fig.&#xA0;<xref rid="aos12909-fig-0001" ref-type="fig">1</xref>B and C). He had a history of recurrent inferotemporal branch retinal artery occlusion (BRAO) from August 2012. He had been diagnosed with Sneddon's syndrome based on the characteristic livedo reticularis (Fig.&#xA0;<xref rid="aos12909-fig-0001" ref-type="fig">1</xref>D), labile hypertension and stroke (Fig.&#xA0;<xref rid="aos12909-fig-0001" ref-type="fig">1</xref>E, arrowheads) (Sneddon <xref rid="aos12909-bib-0004" ref-type="ref">1965</xref>) at Department of Internal Medicine in November 2012. He showed a high serum anticardiolipin antibody level and was treated with warfarin, aspirin, prednisolone (5&#xA0;mg/day) and a hypotensive drug.</p>
      <fig fig-type="Figure" xml:lang="en" id="aos12909-fig-0001" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>(A) Fundus photograph at first visit. Exudative changes including subretinal fluid and hard exudates were found around the aneurysm (arrow) located close to the optic disc. (B, C) Fundus fluorescein angiography (<styled-content style="fixed-case">FFA</styled-content>) before the first subtenon steroid injection (<styled-content style="fixed-case">STTA</styled-content>). (B, arrowheads) The inferotemporal branch artery showed delayed perfusion and (C) optic disc aneurysm was clearly observed. (D, E) Systemic findings of Sneddon's syndrome. (D) Livedo reticularis of the lower leg and (E, arrowheads) T2 magnetic resonance imaging (<styled-content style="fixed-case">MRI</styled-content>) brain scan showing multiple ischaemic lesions. (F&#x2013;I) Optical coherence tomography (<styled-content style="fixed-case">OCT</styled-content>). (F) Subfoveal fluid, retinal oedema and (G, arrowheads) lumen of the optic disc aneurysm were recorded before the initial <styled-content style="fixed-case">STTA</styled-content>. (H) <styled-content style="fixed-case">OCT</styled-content> showed that exudative changes were resolved and (I, arrowheads) aneurysm lumen was regressed, 12&#xA0;months after initial <styled-content style="fixed-case">STTA</styled-content>. (J) <styled-content style="fixed-case">FFA</styled-content> also visualized the diminished aneurysm size 12&#xA0;months after initial <styled-content style="fixed-case">STTA</styled-content>.</p>
        </caption>
        <graphic id="nlm-graphic-1" xlink:href="AOS-94-e517-g001"/>
      </fig>
      <p>Optical coherence tomography (OCT) revealed cystic macular oedema and subfoveal serous retinal detachment and resulting increased central retinal thickness (CRT, 467&#xA0;<italic>&#x3BC;</italic>m, Fig.&#xA0;<xref rid="aos12909-fig-0001" ref-type="fig">1</xref>F). OCT of the optic disc revealed lumen of the optic disc macroaneurysm (Fig.&#xA0;<xref rid="aos12909-fig-0001" ref-type="fig">1</xref>G, arrowheads). Three months following STTA administration (20&#xA0;mg), the subfoveal fluid had disappeared, and CRT had reduced to 200&#xA0;<italic>&#x3BC;</italic>m. An additional STTA was performed 5&#xA0;months after the initial injection to treat the residual macular oedema around the optic disc. Twelve months after the first STTA, the exudative changes had resolved (Fig.&#xA0;<xref rid="aos12909-fig-0001" ref-type="fig">1</xref>H), and the optic disc macroaneurysm had regressed [Fig.&#xA0;<xref rid="aos12909-fig-0001" ref-type="fig">1</xref>I (arrowheads) and J].</p>
      <p>Ultrastructural analysis of skin biopsy in Sneddon's syndrome has revealed a reduction in the capillary lumens due to proliferation of endothelial cells and basement membrane (Lewandowska et&#xA0;al. <xref rid="aos12909-bib-0003" ref-type="ref">2005</xref>). Sixty per cent of patients have antiphospholipid antibodies suggesting the involvement of inflammatory processes (Stockhammer et&#xA0;al. <xref rid="aos12909-bib-0005" ref-type="ref">1993</xref>). Therefore, this syndrome carries a risk of vascular occlusion. In fact, among the rarely reported cases of ocular manifestations of Sneddon's syndrome, six of eight reported cases exhibited retinal art&#x2010;ery occlusion (Jonas et&#xA0;al. <xref rid="aos12909-bib-0002" ref-type="ref">1986</xref>), and one showed retinal vein occlusion (Aggermann et&#xA0;al. <xref rid="aos12909-bib-0001" ref-type="ref">2007</xref>). Our case also included a history of BRAO. However, the current episode was a secondary complication of macroaneurysm, and this is the first case of Sneddon's syndrome associated with retinal macroaneurysm. The distinct vascular wall abnormality with thrombosis related to antiphospholipid antibodies could have induced the aneurysm formation. Moreover, BRAO could have been related to the macroaneurysmal turbulent flow; however, no FFA recordings were performed at the first onset of BRAO.</p>
      <p>Retinal macroaneurysms usually occur in patients aged over sixty with hypertension and unilaterally. They affect the major arterial branches posterior to the equator but are rarely (only 5%) found in the peripapillary region. Our case was atypical in terms of age, sex and aneurysm location. This may be because his aneurysm was related to the&#xA0;vascular changes specific to Sneddon's syndrome. In this case, STTA successfully resolved macular oedema and significantly regressed the macroaneurysm, suggesting the involvement of inflammatory processes in his pathogenesis. This is consistent with the evidence that systemic corticosteroid treatment is beneficial for antiphospholipid antibody&#x2010;positive Sneddon's syndrome affecting various organs.</p>
      <p>In conclusion, here we report the first case of optic disc macroaneurysm with macular oedema as an ocular complication of Sneddon's syndrome and its successful treatment with local steroid injection.</p>
    </sec>
  </body>
  <back>
    <ref-list content-type="cited-references" id="aos12909-bibl-0001">
      <title>References</title>
      <ref id="aos12909-bib-0001">
        <mixed-citation publication-type="journal" id="aos12909-cit-0001">
<string-name>
<surname>Aggermann</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Haas</surname>
<given-names>P</given-names>
</string-name> &amp; <string-name>
<surname>Binder</surname>
<given-names>S</given-names>
</string-name> (<year>2007</year>): <article-title>Central retinal vein occlusion as a possible presenting manifestation of Sneddon syndrome</article-title>. <source>J Neuroophthalmol</source>
<volume>27</volume>: <fpage>240</fpage>&#x2013;<lpage>241</lpage>.<pub-id pub-id-type="pmid">17895826</pub-id></mixed-citation>
      </ref>
      <ref id="aos12909-bib-0002">
        <mixed-citation publication-type="journal" id="aos12909-cit-0002">
<string-name>
<surname>Jonas</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kolble</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Volcker</surname>
<given-names>HE</given-names>
</string-name> &amp; <string-name>
<surname>Kalden</surname>
<given-names>JR</given-names>
</string-name> (<year>1986</year>): <article-title>Central retinal artery occlusion in&#xA0;Sneddon's disease associated with antiphospholipid antibodies</article-title>. <source>Am J Ophthalmol</source>
<volume>102</volume>: <fpage>37</fpage>&#x2013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">3524244</pub-id></mixed-citation>
      </ref>
      <ref id="aos12909-bib-0003">
        <mixed-citation publication-type="journal" id="aos12909-cit-0003">
<string-name>
<surname>Lewandowska</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Wierzba&#x2010;Bobrowicz</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Wagner</surname>
<given-names>T</given-names>
</string-name> et&#xA0;al. (<year>2005</year>): <article-title>Sneddon's syndrome as a disorder of small arteries with endothelial cells proliferation: ultrastructural and neuroimaging study</article-title>. <source>Folia Neuropathol</source>
<volume>43</volume>: <fpage>345</fpage>&#x2013;<lpage>354</lpage>.<pub-id pub-id-type="pmid">16416398</pub-id></mixed-citation>
      </ref>
      <ref id="aos12909-bib-0004">
        <mixed-citation publication-type="journal" id="aos12909-cit-0004">
<string-name>
<surname>Sneddon</surname>
<given-names>IB</given-names>
</string-name> (<year>1965</year>): <article-title>Cerebro&#x2010;vascular lesions and livedo reticularis</article-title>. <source>Br J Dermatol</source>
<volume>77</volume>: <fpage>180</fpage>&#x2013;<lpage>185</lpage>.<pub-id pub-id-type="pmid">14278790</pub-id></mixed-citation>
      </ref>
      <ref id="aos12909-bib-0005">
        <mixed-citation publication-type="journal" id="aos12909-cit-0005">
<string-name>
<surname>Stockhammer</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Felber</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Zelger</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Sepp</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Birbamer</surname>
<given-names>GG</given-names>
</string-name>, <string-name>
<surname>Fritsch</surname>
<given-names>PO</given-names>
</string-name> &amp; <string-name>
<surname>Aichner</surname>
<given-names>FT</given-names>
</string-name> (<year>1993</year>): <article-title>Sneddon's syndrome: diagnosis by skin biopsy and MRI in 17 patients</article-title>. <source>Stroke</source>
<volume>24</volume>: <fpage>685</fpage>&#x2013;<lpage>690</lpage>.<pub-id pub-id-type="pmid">8488523</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
